Ian Ford
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Blood Pressure and Hypertension Studies 21
- Heart Failure Treatment and Management 16
- Cardiac pacing and defibrillation studies 15
- Cardiovascular Function and Risk Factors 14
- Surgery 63
- Lipoproteins and Cardiovascular Health 39
- Co-authors
- James Shepherd (30 shared papers)Stuart M. Cobbe (26 shared papers)Peter W. Macfarlane (22 shared papers)Christopher J. Packard (15 shared papers)Christopher Isles (4 shared papers)James H. McKillop (3 shared papers)A R Lorimer (4 shared papers)Chris J. Packard (37 shared papers)
- Journals
- European Heart Journal (26 papers)European Journal of Heart Failure (16 papers)Atherosclerosis (14 papers)The Lancet (12 papers)Journal of the American College of Cardiology (11 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Ian Ford
352 papers receiving 34.0k citations
Ian Ford's Hit Papers
Peers
Comparison fields: 5 of 203
- Cardiology and Cardiovascular Medicine 9.2k
- Endocrinology, Diabetes and Metabolism 5.2k
- Surgery 9.2k
- Epidemiology 4.0k
- Cancer Research 1.6k
Countries citing papers authored by Ian Ford
This map shows the geographic impact of Ian Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Ford more than expected).
Fields of papers citing papers by Ian Ford
This network shows the impact of papers produced by Ian Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Ford. The network helps show where Ian Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 364 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia Hit paper breakdown → | 1995 | 5964 |
| 2 | Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Hit paper breakdown → | 2002 | 2526 |
| 3 | Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study Hit paper breakdown → | 2003 | 1240 |
| 4 | Diffuse axonal injury in head injury: Definition, diagnosis and grading Hit paper breakdown → | 1989 | 925 |
| 5 | Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial Hit paper breakdown → | 2015 | 817 |
| 6 | Biochemical detection of left-ventricular systolic dysfunction Hit paper breakdown → | 1998 | 796 |
| 7 | Nonparametric Analysis of Statistic Images from Functional Mapping Experiments Hit paper breakdown → | 1996 | 779 |
| 8 | Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease Hit paper breakdown → | 2000 | 701 |
| 9 | Pravastatin and the Development of Diabetes Mellitus Hit paper breakdown → | 2001 | 694 |
| 10 | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2004 | 635 |
| 11 | C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study Hit paper breakdown → | 2002 | 616 |
| 12 | Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study Hit paper breakdown → | 2007 | 597 |
| 13 | Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex Hit paper breakdown → | 2013 | 542 |
| 14 | Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry Hit paper breakdown → | 2012 | 517 |
| 15 | 2001 | 449 | |
| 16 | Electronic health records to facilitate clinical research Hit paper breakdown → | 2016 | 435 |
| 17 | Ischaemic brain damage is still common in fatal non-missile head injury. Hit paper breakdown → | 1989 | 417 |
| 18 | 2004 | 403 | |
| 19 | 2008 | 374 | |
| 20 | Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting Hit paper breakdown → | 2017 | 364 |
About Ian Ford
Ian Ford is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Epidemiology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 364 papers that have together received 35.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (39 papers), Cardiac Imaging and Diagnostics (22 papers), Blood Pressure and Hypertension Studies (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Heart Failure Treatment and Management (16 papers), Acute Ischemic Stroke Management (16 papers), Cardiac pacing and defibrillation studies (15 papers) and Cardiovascular Function and Risk Factors (14 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (9.2k citations), Endocrinology, Diabetes and Metabolism (5.2k citations), Surgery (9.2k citations), Epidemiology (4.0k citations) and Cancer Research (1.6k citations). Ian Ford has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include James Shepherd, Stuart M. Cobbe, Peter W. Macfarlane, Christopher J. Packard, Christopher Isles, James H. McKillop, A R Lorimer, Chris J. Packard, Naveed Sattar and Allan Gaw. Their work appears in journals such as European Heart Journal, European Journal of Heart Failure, Atherosclerosis, The Lancet and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.